Clinical Trials Browser

INDUSTRY × Interventional × Alzheimer Disease × Clear all

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

NCT06125951 2026-02-18

XanaMIA

Phase 2/3 Active not recruiting

247 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular

NCT05637801 2026-02-05

Hope

Phase NA Active not recruiting

670 enrolled

Lymphoid

Alzheimer disease type 1, Alzheimer disease type 2, Alzheimer disease type 4, Alzheimer disease, familial, type 3, Alzheimer Disease 9, Alzheimer Disease 8, Alzheimer Disease 11, Alzheimer Disease 7, Alzheimer Disease 6, Alzheimer Disease 10, Alzheimer Disease 5, Alzheimer Disease 15, Alzheimer Disease 14, Alzheimer Disease 13, Alzheimer Disease 12, Alzheimer Disease 16, Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT05425550 2025-09-22

PRO2

Phase NA Terminated

196 enrolled

Breast

Alzheimer Disease, Breast Neoplasms

NCT04971733 2025-06-10

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Phase 1/2 Completed

8 enrolled 21 charts

CNSLymphoid

Alzheimer Disease, Central Nervous System Diseases, Lymphoma, Follicular

NCT06644573 2025-05-28

PSHW

Phase 1 Not yet recruiting

100 enrolled

Cancer Pain, Psychological Well-Being, Alzheimer Disease, Anxiety Disorders, Combat Disorders, Depression, Sleep Initiation and Maintenance Disorders, Pain, Sleep Deprivation, Stress Disorders, Post-Traumatic, Idiopathic Hypersomnia, Sleep Disorders, Circadian Rhythm, REM Sleep Behavior Disorder, Chronobiology Disorders

NCT05328115 2025-01-31

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

Phase 1 Completed

33 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular

NCT06245031 2024-05-07

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Phase NA Enrolling by invitation

402 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT05321498 2023-09-28

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Phase 2 Withdrawn

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Tauopathies, Cognitive Dysfunction

NCT03371420 2023-04-18